Sun, Dec 21, 2014, 8:24 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • guyat_y guyat_y Nov 19, 2012 7:52 PM Flag

    CORRECTION: SRPT Going Higher With or Without EARLY Approval /// link /// great reading.

    Sarepta Ready To Move Higher
    November 19, 2012 | about: SRPT
    By:EfsInvestors
    Sarepta has a wonderful drug in its pipeline, which can dominate the market for years. Unlike many other drugs, Eteplirsen has support from the public who want this drug to be in the market. It has shown phenomenal results and may force the FDA to approve the drug without phase III trials. Regardless of early approval, the stock will continue to move up in the short and medium term. However, if the early approval is granted - the stock will move up rapidly. In addition, it is extremely unlikely that the company will face competition any time soon. I remain particularly optimistic and confident that Sarepta will provide massive returns to investors.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SRPT
13.21-0.59(-4.28%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.